Open AccessExperimental model proposed to deduce pharmacological evidence of the beta-cell neogenesis activity of Argyrolobium roseum vis-a-vis an evaluation of its hypoglycemic activity
Author(s) -
Gupta Op,
Pavan Malhotra,
Surbhi Kudyar,
Aneeta Singh,
Geetika Gupta
Publication year - 2011
Publication title -
international journal of applied and basic medical research/international journal of applied and basic medical research
Language(s) - English
Resource type - Journals
eISSN - 2248-9606
pISSN - 2229-516X
DOI - 10.4103/2229-516x.91153
Subject(s) - neogenesis , secretagogue , beta cell , beta (programming language) , diabetes mellitus , streptozotocin , endocrinology , medicine , chemistry , pharmacology , insulin , islet , computer science , programming language
Argyrolobium roseum is described in texts for its botanical aspects with no mention of its therapeutic uses. Recently, a solvent fraction of this plant has been reported to possess insulin secretagogue activity.